publication venue for
- Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab.. 26. 2021
- Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy.. 26. 2021
- Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy.. 26. 2021
- The impact of sex and age on distribution of metastases in patients with renal cell carcinoma.. 26. 2021
- Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.. 17. 2011
- Serum HER2 levels determined by two methods in patients with metastatic breast cancer.. 17. 2011
- Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis. 2020
- Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis. 2020
- Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis. 2020
- Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis. 2019
- The concept and evolution of involved site radiation therapy for lymphoma. 2015
- Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis. 2021
- Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and meta-analysis. 2021
- Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis. 2021
- Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. 2020
- Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment. 2020